Sartorius scoops double award at Fisher Scientific European Sales Conference
Company also promoted to Platinum supplier status in Europe.
Sartorius was a double award winner at the Fisher Scientific European Sales Conference in Malta, picking up the awards for Supplier Excellence and Best Booth. These awards coincided with the formal announcement of the promotion of Sartorius to Platinum supplier status in Europe.
The Supplier Excellence Award recognized the excellent cooperation between Fisher Scientific and Sartorius. The year 2017 saw the Sartorius business with Fisher Scientific increase. The award also recognizes Sartorius for supply chain excellence, product quality and marketing support. The Best Booth award, which is voted for by the Fisher Scientific Commercial team, is awarded to the supplier whose booth best incorporates the four values of Fisher Scientific: involvement, intensity, innovation and integrity.
John Collings, European Category Director at Fisher Scientific, announced the change in partnership and explained what it means for the relationship between the two companies. “This change is a significant long-term investment from both companies and will now help us move forward in strategic partnership. This promotion to Platinum will also drive ambitious revenue growth targets, through increased marketing, commercial, supply chain and strategic plans.”
Daniela Winzker-Demes, Sartorius’ Vice President of LPS Sales & Services EMEA, and John Bryson, Director Channel Management Europe, proudly accepted the awards. “The new status is an incentive for us to intensify our cooperation to continuously improve our customers’ experience," said Winzker-Demes. John Bryson commented: “These awards, and the move to Platinum status, reflect our shared success and close partnership with Fisher Scientific. We look forward to another successful year in 2018 as we work together to drive further growth and deliver solutions to our customers.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance